Filing Details
- Accession Number:
- 0001181431-12-060735
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-27 20:03:38
- Reporting Period:
- 2012-11-23
- Filing Date:
- 2012-11-27
- Accepted Time:
- 2012-11-27 20:03:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1365216 | Sucampo Pharmaceuticals Inc. | SCMP | Pharmaceutical Preparations (2834) | 133929237 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1383384 | Sachiko Kuno | 7501 Wisconsin Avenue Suite 600E Bethesda MD 20814-6519 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Disposition | 2012-11-23 | 3,000 | $5.00 | 26,270,633 | No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
| Class A Common Stock | Disposition | 2012-11-26 | 6,405 | $5.00 | 26,264,228 | No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
| Class A Common Stock | Disposition | 2012-11-27 | 2,800 | $5.00 | 26,261,428 | No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
| No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
| No | 4 | S | Indirect | By S&R Technology Holdings, LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Stock | 52,037 | Direct | |
| Class A Common Stock | 148,530 | Indirect | By Husband |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by S&R Technology Holdings, LLC on August 29, 2012.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.01, inclusive. The reporting person undertakes to provide to Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- S&R Technology Holdings, LLC is wholly owned by Dr. Kuno and her husband. Dr. Kuno disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
- Dr. Kuno disclaims beneficial ownership of the reported securities.
Billionaire Hedge Funds
